cytokine release modulator (Lilly)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecytokine release modulator (Lilly)
Drug Alias NameAlzheimers therapeutics (Lilly/Elan)Alzheimers therapeutics (Lilly/Athena)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine release modulators
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A